On Thursday, November 6, 2014, Memorial Sloan Kettering Cancer Center will host its ninth annual Major Trends in Modern Cancer Research lecture for high school and college students. (Members of the public are also welcome to attend.) The event will take place from 5:30–7:30 PM on the first floor of Memorial Sloan Kettering’s Rockefeller Research Laboratories building (430 East 67th Street, between York and First Avenues).
Registration is easy, but finding a seat with a good view isn’t. This event has gotten so popular that the folks at MSKCC needed to set up satellite viewing stations in adjacent conference rooms. Get there a bit early if possible. Light refreshments have traditionally been served before the lectures begin (pizza, chips, fruit, soda, coffee). Single use MetroCards will be made available for any student who needs one to attend.
One point of extra credit will be awarded to all students who attend and complete this assignment for any one of the speakers. (Consult the Extra Credit webpage for more info.) Official attendance is taken by group photo at the end of the event. Place your completed (typed) assignment in my mailbox in the Research Room at any time during the school day on Friday, November 7.
Memorial Sloan Kettering President Craig B. Thompson studies molecular signaling pathways that regulate nutrient uptake and the role these pathways play in the regulation of cell growth and survival.
|Tiny Solutions to Big Problems: The Impact of Nanotechnologies on Cancer Research
Chemist Daniel Heller focuses on biomaterials and nanoscale engineering for molecular sensors and targeted therapeutics.
|Human Pluripotent Stem Cells: A New Model for Studying Disease — Including Cancer
Developmental biologist Danwei Huangfu investigates the fundamental mechanisms that govern cell identity and how they could be exploited therapeutically to manipulate cell fates in regenerative medicine.
|A Study of Extraordinary Responders: Lessons Learned
Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.